BioXcel Therapeutics Inc
NASDAQ:BTAI
Income Statement
Earnings Waterfall
BioXcel Therapeutics Inc
Revenue
|
1.4m
USD
|
Cost of Revenue
|
-1.3m
USD
|
Gross Profit
|
120k
USD
|
Operating Expenses
|
-167.7m
USD
|
Operating Income
|
-167.6m
USD
|
Other Expenses
|
-11.4m
USD
|
Net Income
|
-179.1m
USD
|
Income Statement
BioXcel Therapeutics Inc
Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+171%
|
1
+55%
|
1
+78%
|
1
+19%
|
1
+10%
|
|
Gross Profit | ||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+177%
|
1
+56%
|
1
+77%
|
1
-30%
|
0
-83%
|
|
Operating Income | ||||||||||||||||||||||||||||
Operating Expenses |
(2)
|
(3)
|
(5)
|
(8)
|
(11)
|
(15)
|
(20)
|
(23)
|
(28)
|
(33)
|
(34)
|
(41)
|
(54)
|
(70)
|
(82)
|
(94)
|
(100)
|
(102)
|
(107)
|
(112)
|
(121)
|
(133)
|
(160)
|
(180)
|
(196)
|
(201)
|
(168)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(17)
|
(24)
|
(33)
|
(44)
|
(50)
|
(54)
|
(56)
|
(60)
|
(62)
|
(69)
|
(80)
|
(87)
|
(94)
|
(83)
|
|
Research & Development |
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(10)
|
(15)
|
(17)
|
(22)
|
(25)
|
(26)
|
(33)
|
(44)
|
(53)
|
(58)
|
(60)
|
(56)
|
(52)
|
(53)
|
(57)
|
(61)
|
(71)
|
(91)
|
(100)
|
(109)
|
(107)
|
(84)
|
|
Operating Income |
(2)
N/A
|
(3)
-17%
|
(5)
-76%
|
(8)
-83%
|
(11)
-32%
|
(15)
-38%
|
(20)
-31%
|
(23)
-16%
|
(28)
-23%
|
(33)
-14%
|
(34)
-3%
|
(41)
-23%
|
(54)
-31%
|
(70)
-29%
|
(82)
-18%
|
(94)
-14%
|
(100)
-7%
|
(102)
-2%
|
(107)
-5%
|
(112)
-5%
|
(121)
-8%
|
(133)
-10%
|
(160)
-20%
|
(179)
-12%
|
(195)
-9%
|
(201)
-3%
|
(168)
+16%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(4)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
|
Pre-Tax Income |
(2)
N/A
|
(3)
-17%
|
(5)
-76%
|
(8)
-83%
|
(11)
-30%
|
(15)
-37%
|
(19)
-31%
|
(22)
-15%
|
(28)
-25%
|
(32)
-15%
|
(33)
-4%
|
(41)
-23%
|
(54)
-32%
|
(69)
-29%
|
(82)
-18%
|
(94)
-14%
|
(100)
-7%
|
(102)
-2%
|
(107)
-5%
|
(112)
-5%
|
(122)
-9%
|
(137)
-12%
|
(166)
-21%
|
(187)
-13%
|
(203)
-8%
|
(212)
-4%
|
(179)
+15%
|
|
Net Income | ||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(2)
|
(3)
|
(5)
|
(8)
|
(11)
|
(15)
|
(19)
|
(22)
|
(28)
|
(32)
|
(33)
|
(41)
|
(54)
|
(69)
|
(82)
|
(94)
|
(100)
|
(102)
|
(107)
|
(112)
|
(122)
|
(137)
|
(166)
|
(187)
|
(203)
|
(212)
|
(179)
|
|
Net Income (Common) |
(2)
N/A
|
(3)
-17%
|
(5)
-76%
|
(8)
-83%
|
(11)
-30%
|
(15)
-37%
|
(19)
-31%
|
(22)
-15%
|
(28)
-25%
|
(32)
-15%
|
(33)
-4%
|
(41)
-23%
|
(54)
-32%
|
(69)
-29%
|
(82)
-18%
|
(94)
-14%
|
(100)
-7%
|
(102)
-2%
|
(107)
-5%
|
(112)
-5%
|
(122)
-9%
|
(137)
-12%
|
(166)
-21%
|
(187)
-13%
|
(203)
-8%
|
(212)
-4%
|
(179)
+15%
|
|
EPS (Diluted) |
-0.1
N/A
|
-0.17
-70%
|
-0.29
-71%
|
-0.72
-148%
|
-0.68
+6%
|
-0.94
-38%
|
-1.32
-40%
|
-1.41
-7%
|
-1.76
-25%
|
-2.02
-15%
|
-2.02
N/A
|
-2.14
-6%
|
-2.64
-23%
|
-3
-14%
|
-3.79
-26%
|
-3.81
-1%
|
-4
-5%
|
-3.64
+9%
|
-4.05
-11%
|
-4
+1%
|
-4.36
-9%
|
-4.89
-12%
|
-5.92
-21%
|
-6.53
-10%
|
-6.95
-6%
|
-7.22
-4%
|
-6.15
+15%
|